These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography. Torregrosa I; Montoliu C; Urios A; Andrés-Costa MJ; Giménez-Garzó C; Juan I; Puchades MJ; Blasco ML; Carratalá A; Sanjuán R; Miguel A Heart Vessels; 2015 Nov; 30(6):703-11. PubMed ID: 24989970 [TBL] [Abstract][Full Text] [Related]
11. The level of the biomarkers at the time of nephrology consultation might predict the prognosis of acute kidney injury in hospitalized patients. Renhua L; Miaolin C; Junlin W; Qingwei W; Xiaoping X; Huili D; Weiming Z; Zhaohui N; Jiaqi Q; Yan Y Blood Purif; 2014; 38(2):89-95. PubMed ID: 25342236 [TBL] [Abstract][Full Text] [Related]
12. Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Nejat M; Pickering JW; Devarajan P; Bonventre JV; Edelstein CL; Walker RJ; Endre ZH Kidney Int; 2012 Jun; 81(12):1254-62. PubMed ID: 22418979 [TBL] [Abstract][Full Text] [Related]
13. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL). van de Vrie M; Deegens JK; van der Vlag J; Hilbrands LB Am J Kidney Dis; 2014 Apr; 63(4):573-6. PubMed ID: 24268306 [TBL] [Abstract][Full Text] [Related]
14. Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury. Parr SK; Clark AJ; Bian A; Shintani AK; Wickersham NE; Ware LB; Ikizler TA; Siew ED Kidney Int; 2015 Mar; 87(3):640-8. PubMed ID: 25229339 [TBL] [Abstract][Full Text] [Related]
15. Urinary biomarkers and progression of AKI in patients with cirrhosis. Belcher JM; Garcia-Tsao G; Sanyal AJ; Thiessen-Philbrook H; Peixoto AJ; Perazella MA; Ansari N; Lim J; Coca SG; Parikh CR; Clin J Am Soc Nephrol; 2014 Nov; 9(11):1857-67. PubMed ID: 25183658 [TBL] [Abstract][Full Text] [Related]
16. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study. Bhavsar NA; Köttgen A; Coresh J; Astor BC Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304 [TBL] [Abstract][Full Text] [Related]
17. Clinical implication of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in patients with acute paraquat intoxication. Gil HW; Yang JO; Lee EY; Hong SY Clin Toxicol (Phila); 2009 Nov; 47(9):870-5. PubMed ID: 19827907 [TBL] [Abstract][Full Text] [Related]
18. Urinary neutrophil gelatinase-associated lipocalin identifies critically ill young children with acute kidney injury following intensive care admission: a prospective cohort study. Zwiers AJ; de Wildt SN; van Rosmalen J; de Rijke YB; Buijs EA; Tibboel D; Cransberg K Crit Care; 2015 Apr; 19(1):181. PubMed ID: 25895828 [TBL] [Abstract][Full Text] [Related]
19. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388 [TBL] [Abstract][Full Text] [Related]
20. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]